...
首页> 外文期刊>World journal of gastroenterology : >Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients.
【24h】

Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients.

机译:中国消化系统癌症患者NM23H1遗传不稳性与临床病理特征的关系。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM: To study the relationship between nm23H1 gene genetic instability and its clinical pathological characteristics in Chinese digestive system cancer patients. METHODS: Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) was used to analyze the microsatellite instability (MSI) and loss of heterozygosity (LOH). Immunohistochemistry was employed to detect the expression of nm23H1. RESULTS: The MSI was higher in TNM stage I + II than in stage III + IV of gastric, colonic and gallbladder carcinomas. The LOH was higher in TNM stage III + IV than in stage I + II of gastric, colonic and hepatocellular carcinomas. Lymphatic metastasis was also observed. The expression of nm23H1 protein was lower in TNM stage III + IV than in stage I + II of these tumors and in patients with lymphatic metastasis.The nm23H1 protein expression was higher in the LOH negative group than in the LOH positive group. CONCLUSION: MSI and LOH may independently control the biological behaviors of digestive system cancers. MSI could serve as an early biological marker of digestive system cancers. Enhanced expression of nm23H1 protein could efficiently inhibit cancer metastasis and improve its prognosis. LOH mostly appears in late digestive system cancer.
机译:目的:研究中国消化系统癌症患者NM23H1基因遗传不稳定与临床病理特征的关系。方法:采用聚合酶链反应 - 单链构象多态性(PCR-SSCP)分析微卫星不稳定性(MSI)和杂合性的损失(LOH)。使用免疫组织化学检测NM23H1的表达。结果:MSI在TNM阶段I + II中较高,而不是胃,结肠和胆囊癌阶段III + IV。 TNM阶段III + IV的LOH高于胃,结肠和肝细胞癌的第I + II阶段。还观察到淋巴结转移。 TNM阶段III + IV的NM23H1蛋白的表达低于这些肿瘤的第I + II期和淋巴结转移的患者。在LOH阴性组中NM23H1蛋白表达比LOH阳性较高。结论:MSI和LOH可独立控制消化系统癌症的生物学行为。 MSI可以作为消化系统癌症的早期生物学标志物。增强NM23H1蛋白的表达可以有效地抑制癌症转移并改善预后。 LOH主要出现在晚期消化系统癌症中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号